Learn More
Medchemexpress LLC Atrasentan hydrochloride | 195733-43-8 | C29H39ClN2O6 | 100 MG

Supplier: Medchemexpress LLC HY15403A100MG
Atrasentan hydrochloride is a selective endothelin A receptor antagonist, exhibiting an IC50 of 0.0551 nM for ETA. It is designated for research purposes only and is not intended for patient use. This compound presents as an off-white to gray solid with a molecular weight of 547.08.
- Effectively inhibits the growth of LNCaP and C4-2b prostate cancer cells.
- Significantly induces several CYPs and drug transporters.
- Acts as a moderate P-gp inhibitor and a weak BCRP inhibitor.
- Suppresses pressor response initiated by big endothelin-1 in pithed rats.
- Partially inhibits C4-2b tumor progression within the bone environment in the SCID-hu model.
- Soluble in DMSO and water with specific preparation requirements.
- Recommended storage at 4°C in sealed conditions, away from moisture.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.